AtonRa Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $510K | Sell |
|
|||||
|
2023
Q3 | $520K | Sell |
|
|||||
|
2023
Q2 | $686K | Sell |
|
|||||
|
2023
Q1 | $755K | Sell |
|
|||||
|
2022
Q4 | $1.01M | Sell |
|
|||||
|
2022
Q3 | $1.21M | Sell |
|
|||||
|
2022
Q2 | $886K | Sell |
|
|||||
|
2022
Q1 | $1.56M | Buy |
|
|||||
|
2021
Q4 | $1.6M | Buy |
|
|||||
|
2021
Q3 | $1.64M | Buy |
|
|||||
|
2021
Q2 | $1.37M | Sell |
|
|||||
|
2021
Q1 | $2.85M | Buy |
|
|||||
|
2020
Q4 | $960K | Buy |
|